Skip to main content
Advertisement
Advertisement
NVST
NVST logo
Envista Holdings Corporation Common stock, $0.01 par value per share
23.27
USD
Sponsored
-0.48
-2.02%
Nov 19, 15:59 UTC -5
Closed
exchange

After-Market

23.27

0.00
+0.02%

Envista Holdings Corporation Common stock, $0.01 par value per share (NVST) Earnings

NVST Earnings Reports

Positive Surprise Ratio

NVST beat 22 of 29 last estimates.

76%

Next Report

Date of Next Report
Feb 03, 2027
Estimate for Q4 26 (Revenue/ EPS)
$761.49M
/
$0.40
Implied change from Q3 26 (Revenue/ EPS)
+10.12%
/
--
Implied change from Q4 25 (Revenue/ EPS)
+1.45%
/
+5.26%

Envista Holdings Corporation Common stock, $0.01 par value per share earnings per share and revenue

On Nov 04, 2026, NVST reported earnings of 0.40 USD per share (EPS) for Q3 26, beating the estimate of 0.36 USD, resulting in a 10.13% surprise. Revenue reached 691.50 million, compared to an expected 702.51 million, with a -1.57% difference. The market reacted with a -8.20% price change (close before vs. close after earnings).
Looking ahead to Q4 26, -- analysts forecast an EPS of 0.40 USD, with revenue projected to reach 761.49 million USD, implying an increase of 0.00% EPS, and increase of 10.12% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Omeros Corporation
Report Date
Nov 16, 2026 For Q3 26
Estimate
$0.03
Actual
$0.06
Surprise
+96.08%
logo
Sanara MedTech Inc. Common Stock
Report Date
Nov 12, 2026 For Q3 26
Estimate
$0.06
Actual
-$0.16
Surprise
-361.44%
logo
Oramed Pharmaceuticals Inc.
Report Date
Nov 12, 2026 For Q3 26
Estimate
$0.43
Actual
$0.43
Surprise
-1.96%
logo
MacroGenics, Inc.
Report Date
Nov 12, 2026 For Q3 26
Estimate
-$0.06
Actual
-$0.32
Surprise
-367.15%
logo
Glass House Brands Inc.
Report Date
Nov 16, 2026 For Q3 26
Estimate
-$0.04
Actual
-$0.14
Surprise
-191.06%
logo
Immucell Corp
Report Date
Nov 12, 2026 For Q3 26
Estimate
-
Actual
$0.10
Surprise
-
logo
FitLife Brands, Inc. Common Stock
Report Date
Nov 16, 2026 For Q3 26
Estimate
$0.24
Actual
$0.16
Surprise
-34.64%
logo
Rockwell Medical, Inc. (DE) Common Stock
Report Date
Nov 12, 2026 For Q3 26
Estimate
-$0.13
Actual
-$0.37
Surprise
-179.03%
logo
Modular Medical, Inc. Common Stock
Report Date
Nov 16, 2026 For Q2 26
Estimate
-$0.10
Actual
-$0.90
Surprise
-782.35%
logo
Cytosorbents Corp.
Report Date
Nov 12, 2026 For Q3 26
Estimate
-$0.91
Actual
-$0.57
Surprise
+36.82%
FAQ
For Q3 2026, Envista Holdings Corporation Common stock, $0.01 par value per share reported EPS of $0.40, beating estimates by 10.13%, and revenue of $691.50M, -1.57% below expectations.
The stock price moved down -8.2%, changed from $27.19 before the earnings release to $24.96 the day after.
The next earning report is scheduled for Feb 03, 2027.
Based on -- analysts, Envista Holdings Corporation Common stock, $0.01 par value per share is expected to report EPS of $0.40 and revenue of $761.49M for Q4 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement